Lindson, Nicola and Theodoulou, Annika and Ordóñez-Mena, JM and Fanshawe, TR and Sutton, AJ and Livingstone-Banks, Jonathan and Hajizadeh, A and Zhu, S and Aveyard, P and Freeman, SC and Agrawal, S and Hartmann-Boyce, Jamie (2023) Clinical question: How effective are medications and e-cigarettes for quitting smoking, and what works best? Cochrane Clinical Answers .

Tort, Sera and Husein-ElAhmed, Husein (2023) Clinical question: For adults with opioid‐refractory cancer pain, what are the benefits and harms of nabiximols (tetrahydrocannabinol (THC) and cannabidiol (CBD))? Cochrane Clinical Answers .

Livingstone-Banks, Jonathan (2023) Clinical question: How does bupropion compare with placebo for promoting smoking cessation in adolescents and adults? Cochrane Clinical Answers .

Kuperman, Sophia and Magalhães, Pedro V (2023) Clinical question: Can adding baclofen to psychosocial treatment improve outcomes for people with alcohol use disorder? Cochrane Clinical Answers .

Livingstone-Banks, Jonathan (2023) Clinical question: How does bupropion compare with varenicline or nicotine replacement therapies (NRTs) for promoting smoking cessation in adolescents and adults? Cochrane Clinical Answers .

Livingstone-Banks, Jonathan (2023) Clinical question: What are the effects of adding bupropion or fluoxetine to other treatments compared with using other treatments alone for people trying to quit smoking? Cochrane Clinical Answers .

Livingstone-Banks, Jonathan (2023) Clinical question: What are the benefits and harms of opioid agonist treatment for people who are dependent on pharmaceutical opioids? Cochrane Clinical Answers .

Ciapponi, Agustín and Tort, Sera (2022) Clinical question: How do heated tobacco products (HTPs) and cigarette smoking compare in terms of safety? Cochrane Clinical Answers .

Gupta, Adarsh (2022) Clinical question: In adults with multiple sclerosis, what are the effects of cannabis and cannabinoids for symptomatic treatment? Cochrane Clinical Answers , (2022) .

Livingstone-Banks, Jonathan (2021) Clinical question: What are the benefits and harms of psychosocial interventions for reducing parental alcohol and drug misuse? Cochrane Clinical Answers , (2021) .

Tort, Sera and Pettersen, Karen (2021) Clinical question: Does varenicline or nicotine replacement therapy (NRT) help prevent weight gain after smoking cessation? Cochrane Clinical Answers , (2021) .

Livingstone-Banks, Jonathan (2021) Clinical question: What are the effects of standardized tobacco packaging design in reducing tobacco use among adults? Cochrane Clinical Answers .

Ciapponi, Agustín (2021) Clinical question: What are the effects of smoking cessation on anxiety and depression? Cochrane Clinical Answers .

Burch, Jane and Jackson, Christopher (2021) Clinical question: How does mode of delivery impact effectiveness of motivational and behavioral smoking cessation interventions? Cochrane Clinical Answers .

Burch, Jane and Jackson, Christopher (2021) Clinical question: How does type of provider impact effectiveness of motivational and behavioral smoking cessation interventions? Cochrane Clinical Answers .

Burch, Jane and Tort, Sera (2020) Clinical question: What is the effect of implementing workplace‐based health promotion policies and practices? Cochrane Clinical Answers .

Burch, Jane and Tort, Sera (2020) Clinical question: How do tailored and non‐tailored self‐help interventions compare with no self‐help or each other for smoking cessation? Cochrane Clinical Answers .

Burch, Jane and Shah, Rajeev (2020) Clinical question: What are the effects on respiratory and cardiovascular outcomes of comprehensive legislative smoking bans for reducing harm from secondhand smoke exposure, smoking prevalence, and tobacco consumption? Cochrane Clinical Answers .

Ciapponi, Agustín (2020) Clinical question: For individuals with opiate use disorders, what are the effects of dihydrocodeine for detoxification? Cochrane Clinical Answers .

Nabhan, Ashraf and Kamel, Menna (2020) Clinical question: How does nicotine replacement therapy as an adjunct to behavioral support compare with behavioral support alone or with placebo in promoting smoking cessation for pregnant women? Cochrane Clinical Answers .

Burch, Jane and Magalhães, Pedro V (2020) Clinical question: What are the effects of a therapeutic community for drug‐using offenders with co‐occurring mental health problems? Cochrane Clinical Answers .

Ciapponi, Agustín (2020) Clinical question: How do different smoking reduction interventions compare in terms of long‐term (≥ 6 months) smoking cessation? Cochrane Clinical Answers .

Ciapponi, Agustín (2020) Clinical question: For female offenders, how does increased intensity of discharge planning plus community‐based case management impact drug and alcohol use after release? Cochrane Clinical Answers .

Ciapponi, Agustín (2020) Clinical question: Does RCT evidence indicate that manualized Alcoholics Anonymous (AA) or other 12‐step programs offer benefit over alternative interventions for people with alcohol use disorder? Cochrane Clinical Answers .

Livingstone-Banks, Jonathan (2020) Clinical question. How effective is exercise as an adjunct to smoking cessation support for promoting smoking cessation in adults? Cochrane Clinical Answers .

Vincent, E Chris (2020) Clinical question: What are the benefits and harms of psychosocial interventions in people with both severe mental illness and substance misuse? Cochrane Clinical Answers .

Hong, Bosun (2019) Clinical question: How does real‐time video counseling compare with telephone counseling for adults attempting to quit smoking? Cochrane Clinical Answers .

Pattersen, Karen and Tort, Sera (2019) Clinical question: Is randomized controlled trial evidence available to support the use of mobile phone–based interventions for smoking cessation? Cochrane Clinical Answers .

Vincent, E Chris (2019) Clinical question: Does motivational interviewing help adults and adolescents quit smoking? Cochrane Clinical Answers .

Burch, Jane and Tort, Sera (2019) Clinical question: Can training health professionals to identify smokers and deliver smoking cessation interventions increase the numbers of patients quitting smoking? Cochrane Clinical Answers .

Kavirajan, Harish (2019) Clinical question: Can relapse prevention interventions help adults who have received assistance to stop smoking maintain abstinence? Cochrane Clinical Answers .

Kavirajan, Harish (2019) Clinical question: Can relapse prevention interventions help adults who have quit smoking on their own to maintain abstinence? Cochrane Clinical Answers .

Chepkin, Samantha C (2019) Clinical question: How does hypnotherapy compare with behavioral treatments for promoting smoking cessation in adults? Cochrane Clinical Answers .

Kavirajan, Harish (2019) Clinical question: Can relapse prevention interventions help adults who have quit smoking while hospitalized to maintain abstinence? Cochrane Clinical Answers .

Livingstone-Banks, Jonathan (2019) Clinical question: Can psychosocial interventions, given alone or added to treatment as usual, improve outcomes for people who misuse psychostimulants? Cochrane Clinical Answers .

Kavirajan, Harish (2019) Clinical question: Do adjunctive interventions to standard behavioral support increase adherence to medications for tobacco dependence? Cochrane Clinical Answers .

Kavirajan, Harish (2019) Can behavioral prevention interventions help women who have quit smoking while pregnant to maintain abstinence? Cochrane Clinical Answers .

Ciapponi, Agustín (2019) Clinical question: How do effects of active nicotine replacement therapy (NRT) differ across different genetic biomarkers for people trying to quit smoking? Cochrane Clinical Answers .

Chepkin, Samantha C (2019) Clinical question: What are the effects of intensifying the level of behavioral support given to people taking pharmacotherapy for smoking cessation? Cochrane Clinical Answers .

Hong, Bosun (2019) Clinical question: Can smokers be helped to reduce the harm caused by cigarette smoking by smoking fewer cigarettes or using different tobacco products? Cochrane Clinical Answers .

Kavirajan, Harish (2019) Clinical question: What are the effects of providing pregnant women with incentives to stop smoking? Cochrane Clinical Answers .

Kavirajan, Harish (2019) Clinical question: Can providing incentives to stop smoking to adult smokers of mixed populations increase quit rates? Cochrane Clinical Answers .

Burch, Jane and Tort, Sera (2019) Clinical question: What are the effects of mass media antismoking campaigns on smoking/tobacco use in young people (< 25 years of age)? Cochrane Clinical Answers .

Ciapponi, Agustín (2019) Clinical question: Can system change interventions help to stop smoking? Cochrane Clinical Answers .

Kavirajan, Harish (2019) Clinical question: How does implementation of a family‐based prevention program compare with no intervention or an adolescent‐based program provided only to prevent or reduce alcohol use in adolescents? Cochrane Clinical Answers .

Burch, Jane and Tort, Sera (2019) Clinical question: Do family/carer smoking control programs improve children's health? Cochrane Clinical Answers .

Burch, Jane and Ciapponi, Agustín (2019) Clinical question: Can use of electronic cigarettes help people quit smoking? Cochrane Clinical Answers .

Tort, Sera and Ciapponi, Agustín (2019) Clinical question: Does biomedical risk assessment help as an adjunct to smoking cessation interventions? Cochrane Clinical Answers .

Davis, Mark (2018) Clinical question. What are the benefits and harms of naloxone for opiate‐exposed newborn infants? Cochrane Clinical Answers .

Kavirajan, Harish (2018) Clinical question: How do single over‐the‐counter nicotine replacement therapy (NRT) agents compare with placebo/no NRT agents for smoking cessation? Cochrane Clinical Answers .

Burch, Jane and Tort, Sera (2018) Clinical question: Can one‐to‐one partner support for smokers increase smoking cessation? Cochrane Clinical Answers .

Burch, Jane and Kavirajan, Harish (2018) Clinical question: What are the benefits and harms of psychostimulant drugs for people with cocaine dependence? Cochrane Clinical Answers .

Burch, Jane and Magalhães, Pedro V (2018) Clinical question: Can brief interventions reduce risky alcohol consumption in adolescents and adults who have experienced harm due to excessive drinking? Cochrane Clinical Answers .

Kavirajan, Harish (2018) Clinical question: How do tailored and non‐tailored internet‐based interventions for smoking cessation in adults compare with active and inactive controls and with each other? Cochrane Clinical Answers .

Burch, Jane and Tort, Sera (2018) Clinical question: In people with cannabis use disorder, can motivational enhancement therapy or cognitive‐behavioral therapy improve outcomes to a greater extent than delayed treatment? Cochrane Clinical Answers .

Burch, Jane and Magalhães, Pedro V (2018) Clinical question: What are the benefits and harms of nursing interventions aimed at aiding smoking cessation? Cochrane Clinical Answers .

Burch, Jane and Magalhães, Pedro V (2018) Clinical question: How do personalized digital interventions to reduce hazardous and harmful alcohol consumption compare with no/minimal intervention in community‐dwelling populations? Cochrane Clinical Answers .

Ronellenfitsch, Ulrich (2018) Clinical question: What are the benefits and harms of glucocorticosteroids in adults with alcoholic hepatitis? Cochrane Clinical Answers .

Burch, Jane and Tort, Sera (2018) Clinical question: What are the effects of tobacco cessation interventions for young people? Cochrane Clinical Answers .

Burch, Jane and Tort, Sera (2018) Clinical question: What are the effects of opioid substitution therapy and needle syringe programs for preventing hepatitis C transmission in people who inject drugs? Cochrane Clinical Answers .

Gruenebaum, Dave (2018) Clinical question: Can psychosocial interventions encourage smoking cessation in people with coronary heart disease? Cochrane Clinical Answers .

Burch, Jane and Tort, Sera (2017) Clinical question: Can group behavior therapy programs increase smoking abstinence rates? Cochrane Clinical Answers .

Kavirajan, Harish (2017) Clinical question: What are the effects of the Smokefree Class Competition incentive for preventing smoking among children and adolescents? Cochrane Clinical Answers .

Burch, Jane and Tort, Sera (2017) Clinical question: For people with opioid dependence, does supervised dosing of their long‐acting opioid substitution medication help to improve outcomes? Cochrane Clinical Answers .

Burch, Jane and Tort, Sera (2017) Clinical question: Can individual behavioral counseling increase smoking abstinence rates? Cochrane Clinical Answers .

Burch, Jane and Tort, Sera (2017) Clinical question: What are the effects of glucocorticosteroids and/or pentoxifylline in people with alcohol‐related liver disease? Cochrane Clinical Answers .

Villyen Motaze, Nkengafac (2017) Clinical question: How does feedback compare with usual care or less intensive interventions for helping women stop smoking during pregnancy? Cochrane Clinical Answers .

Villyen Motaze, Nkengafac (2017) Clinical question: How does counselling compare with usual care or less intensive interventions for helping women stop smoking during pregnancy? Cochrane Clinical Answers .

Villyen Motaze, Nkengafac (2017) Clinical question: How do financial incentives compare with usual care or less intensive interventions for helping women stop smoking during pregnancy? Cochrane Clinical Answers .

Villyen Motaze, Nkengafac (2017) Clinical question: How does health education or exercise compare with usual care or less intensive interventions for helping women stop smoking during pregnancy? Cochrane Clinical Answers .

Kavirajan, Harish (2017) Clinical question: What are the benefits of interventions to reduce smoking in people receiving concurrent treatment for or in recovery from alcohol and other drug dependence? Cochrane Clinical Answers .

Burch, Jane and Magalhães, Pedro V (2017) Clinical question: How does buprenorphine compare with methadone or adrenergic agonists in people undergoing opioid withdrawal? Cochrane Clinical Answers .

Burch, Jane and Magalhães, Pedro V (2017) Clinical question: How do alpha2‐adrenergic agonists compare with placebo or methadone for management of opioid withdrawal? Cochrane Clinical Answers .

Burch, Jane and Tort, Sera (2017) Clinical question: How does portion size or package or tableware size affect selection and consumption of food and tobacco? Cochrane Clinical Answers .

Burch, Jane and Martin-Lopez, Juliana Ester (2017) Clinical question: How do bupropion, nicotine replacement therapy and varenicline for smoking cessation compare? Cochrane Clinical Answers .

Tort, Sera and Magalhães, Pedro V (2017) Clinical question: What are the effects of opioid antagonists in people with alcohol dependence? Cochrane Clinical Answers .

Burch, Jane and Preda, Adrian (2017) Clinical question: What are the benefits and harms of antipsychotic medications in people with cocaine dependence? Cochrane Clinical Answers .

Bunt, Christopher (2017) Clinical question: How does varenicline compare with bupropion or nicotine‐replacement therapy for smoking cessation? Cochrane Clinical Answers .

Burch, Jane and Martin‐Lopez, Juliana Ester (2016) Clinical question: What are the effects of motivational interviewing for the prevention of alcohol misuse in young adults, mostly assessed as higher risk? Cochrane Clinical Answers .

Burch, Jane and Tort, Sera (2016) Clinical question: How do different pharmacological interventions compare for the treatment of alcohol withdrawal syndrome? Cochrane Clinical Answers .

Magalhães, Pedro V (2016) Clinical question: What are the effects of brief interventions in heavy alcohol users admitted to general hospital wards? Cochrane Clinical Answers .

Gruenebaum, Dane (2016) Clinical question: How does pentoxifylline affect outcomes in people with alcoholic hepatitis? Cochrane Clinical Answers .

Kavirajan, Harish (2016) Clinical question: Can brief school‐based interventions improve outcomes for substance‐using adolescents? Cochrane Clinical Answers .

Vincent, E Chris (2016) Clinical question: Does information on alcohol use in one's peer group affect drinking habits in university and college students? Cochrane Clinical Answers .

Kavirajan, Harish (2016) Clinical question: In people with depression during opioid agonist treatment for opioid dependence, what are the effects of antidepressants? Cochrane Clinical Answers .

Hughes, John (2016) Clinical question: Do family‐based programs prevent smoking by children and adolescents? Cochrane Clinical Answers .

Magalhães, Pedro V (2015) Clinical question: What are the effects of psychosocial treatments as an adjunct to pharmacological treatments in people undergoing opioid detoxification? Cochrane Clinical Answers .

Preda, Adrian (2015) Clinical question: Is there randomized controlled trial evidence to support the use of motivational interviewing in people with substance abuse? Cochrane Clinical Answers .

Magalhães, Pedro V (2015) Clinical question: What are the benefits and harms of buprenorphine maintenance versus placebo or methadone maintenance in people with opioid dependence? Cochrane Clinical Answers .

Cayley, William (2015) Clinical question: Can acamprosate (with or without naltrexone) support continued abstinence after detoxification in alcohol‐dependent people? Cochrane Clinical Answers .

Vincent, E Chris (2015) Clinical question: In people with anxiety and comorbid alcohol use disorders, what are the benefits and harms of paroxetine? Cochrane Clinical Answers .

Davies, Mark (2015) Clinical question: What are the benefits and harms of naloxone in opiate‐exposed newborn infants? Cochrane Clinical Answers .

Burch, Jane and Gruenebaum, Dane (2015) Clinical question: What are the effects of benzodiazepines in people with alcohol withdrawal? Cochrane Clinical Answers .